Skip to main content

Sorafenib plus HAIC a favorable therapeutic option for HCC with major portal vein tumor thrombosis

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Sorafenib plus HAIC a favorable therapeutic option for HCC with major portal vein tumor thrombosis

User login

Username

Password

Reset your password

Type	Lead	score